| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |